二甲雙胍聯(lián)合優(yōu)思悅治療肥胖型多囊卵巢綜合征的臨床效果分析
【摘要】目的:分析在優(yōu)思悅基礎(chǔ)上服用二甲雙胍對(duì)肥胖型多囊卵巢綜合征患者性激素、胰島素抵抗的改善作用。方法:選取100例肥胖型多囊卵巢綜合征患者作為研究對(duì)象,并劃分至兩個(gè)小組內(nèi),分別給予單一優(yōu)思悅治療(對(duì)照組)和優(yōu)思悅聯(lián)合二甲雙胍治療(觀察組),連續(xù)治療3個(gè)療程,并觀察兩組患者的療效。結(jié)果:治療后,相較于對(duì)照組,觀察組總有效率、排卵率、妊娠率及雌二醇均更高,BMI、IRI、促卵泡生成素、促黃體生成素以及睪酮均更低,各項(xiàng)數(shù)據(jù)均存在差異性,P
【關(guān)鍵詞】二甲雙胍;優(yōu)思悅;肥胖型多囊卵巢綜合征;性激素水平
基金項(xiàng)目:2023年度廣西壯族自治區(qū)衛(wèi)健委西醫(yī)類別自籌經(jīng)費(fèi)科研課題《體重管理聯(lián)合二甲雙胍在肥胖型多囊卵巢綜合癥合并不孕患者中的臨床應(yīng)用》(Z-A20230309)
Clinical efficacy analysis of metformin combined with Yousiyue in the treatment of obese polycystic ovary syndrome
WEI Fangxiu, CHEN Mei, MO Meichun, MO Linling, LI Cuiming
Guangxi Zhuang Autonomous Region Maternal and Child Health Hospital, Nanning, Guangxi 530000, China
【Abstract】Objective:To analyze the improvement effect of taking metformin based on Yousiyue on sex hormones and insulin resistance in patients with obese polycystic ovary syndrome.Methods:100 patients with obese polycystic ovary syndrome were selected as the research subjects,and they were divided into two groups.They were treated with single Yousiyue (the control group) and Yousiyue combined with metformin (the observation group) for three consecutive courses of treatment,and the therapeutic effects of the two groups of patients were observed.Results:After treatment,compared to the control group,the total effective rate,ovulation rate,pregnancy rate and estradiol of the observation group were higher,the BMI,IRI,follicle stimulating hormone,luteinizing hormone and testosterone were lower,and there were differences in all data,P
【Key Words】Metformin; Yousiyue; Obese polycystic ovary syndrome; Sex hormone levels
多囊卵巢綜合征是一種女性常見的內(nèi)分泌代謝異常病癥,一般高發(fā)于育齡期,近年來在青春期中的發(fā)病率也較高[1]。(剩余4202字)
- 優(yōu)質(zhì)護(hù)理在剖宮產(chǎn)產(chǎn)婦護(hù)理中的實(shí)...
- 新型家庭醫(yī)生簽約服務(wù)對(duì)促進(jìn)轄區(qū)...
- 無痛分娩聯(lián)合縮宮素及人工破膜對(duì)...
- 盆底肌訓(xùn)練與盆底電刺激在產(chǎn)婦產(chǎn)...
- 二甲雙胍聯(lián)合優(yōu)思悅治療肥胖型多...
- 米非司酮聯(lián)合腹腔鏡子宮肌瘤剔除...
- 卵巢扭轉(zhuǎn)的常規(guī)超聲表現(xiàn)分析...
- 宮腔鏡下輸卵管插管通液治療不孕...
- 溶血三項(xiàng)在新生兒溶血檢測(cè)中的靈...
- 不同年齡段上消化道出血患者臨床...
- 胃腸充盈法超聲造影用于體檢人群...
- 基于Bobath理念的治療性體...
- 化學(xué)發(fā)光免疫法在腫瘤生物標(biāo)志物...
- 生化檢驗(yàn)中肝功能指標(biāo)檢測(cè)在肝硬...
- 微創(chuàng)拔牙術(shù)在下頜阻生智齒拔除中...
- 體位優(yōu)化干預(yù)聯(lián)合個(gè)體化疼痛管理...
- 1例尖吻蝮咬傷致腦梗死應(yīng)用阿替...
- 體外膈肌起搏治療結(jié)合呼吸訓(xùn)練法...
- 學(xué)校結(jié)核病篩查對(duì)早期發(fā)現(xiàn)結(jié)核病...
- 接塵作業(yè)對(duì)外周血象和肝功能指標(biāo)...
- 門冬胰島素配合地特胰島素治療妊...
- 阿司匹林及拉貝洛爾在妊娠期高血...
- 抗生素聯(lián)合治療老年慢阻肺患者社...
- 應(yīng)用PDCA法踐行臨床藥師圍術(shù)...
- 內(nèi)鏡下注射硬化劑治療乙型肝炎肝...
- 沙庫(kù)巴曲纈沙坦鈉聯(lián)合琥珀酸美托...
- 鹽酸羅哌卡因聯(lián)合舒芬太尼在椎管...
- 肺部感染患者采用中成藥物制劑聯(lián)...
- 炙甘草湯加減聯(lián)合穩(wěn)心顆粒治療冠...
- 柴胡疏肝散加減治療肝郁型不寐的...
- 安坤止血湯聯(lián)合地屈孕酮治療圍絕...
- 個(gè)性化護(hù)理在小兒肺炎支原體感染...
- 學(xué)齡期哮喘兒童哮喘家庭控制水平...
- 腹腔鏡下全子宮切除術(shù)患者行手術(shù)...
- 需求導(dǎo)向性干預(yù)下行無縫隙護(hù)理在...
- 乳腺癌化療患者應(yīng)用PICC和靜...
- 探討階段式健康教育模式在試管嬰...
- 積極心理學(xué)理論下護(hù)理在細(xì)菌性陰...
- 計(jì)劃行為理論指導(dǎo)下的護(hù)理對(duì)老年...
- 優(yōu)質(zhì)護(hù)理模式在動(dòng)靜脈內(nèi)瘺術(shù)后血...
- 綜合護(hù)理對(duì)高血壓合并冠心病患者...
- 互聯(lián)網(wǎng)系統(tǒng)性社區(qū)護(hù)理對(duì)糖尿病腎...
- 人性化護(hù)理干預(yù)對(duì)人工髖關(guān)節(jié)置換...
- 早期肢體功能訓(xùn)練在腦梗死患者護(hù)...
- 醫(yī)護(hù)一體化急診急救護(hù)理流程應(yīng)用...
- 敘事護(hù)理的心理干預(yù)對(duì)冠心病心絞...
- 慢性腎衰竭患者血液透析治療中的...
- 基于保護(hù)動(dòng)機(jī)理論的急性脂源性胰...
- 綜合護(hù)理干預(yù)對(duì)精神分裂癥患者臨...
- 內(nèi)鏡下胃息肉切除術(shù)中運(yùn)用綜合護(hù)...
- 早期腸內(nèi)營(yíng)養(yǎng)在結(jié)腸癌術(shù)后護(hù)理中...
- 優(yōu)質(zhì)護(hù)理對(duì)疝氣手術(shù)患者術(shù)后的效...
- 全面護(hù)理模式在膽結(jié)石膽絞痛護(hù)理...
- 森田心理護(hù)理在抑郁癥患者護(hù)理中...
- 探討綜合護(hù)理干預(yù)在提高長(zhǎng)程視頻...
- 用藥指導(dǎo)對(duì)老年糖尿病患者血糖控...
- 以HAPA為導(dǎo)向的肺康復(fù)訓(xùn)練方...
- 健康行為改變整合理論下健康教育...
- 觀察強(qiáng)化康復(fù)護(hù)理模式對(duì)腦梗死偏...
- 康復(fù)護(hù)理對(duì)膝骨關(guān)節(jié)炎患者疼痛及...
- 早期腸內(nèi)營(yíng)養(yǎng)耐受性分級(jí)護(hù)理在I...
- 基于“互聯(lián)網(wǎng)+醫(yī)院-家庭”雙向...
- 精細(xì)化質(zhì)控管理對(duì)消毒供應(yīng)室手術(shù)...
- 醫(yī)護(hù)一體化模式在眼底病患者管理...
- 護(hù)理營(yíng)養(yǎng)指導(dǎo)干預(yù)對(duì)慢性腎臟病患...
- IKAP理論指導(dǎo)下的護(hù)理干預(yù)對(duì)...